154 related articles for article (PubMed ID: 36698136)
1. PCDH17 gene promoter methylation status in a cohort of Egyptian women with epithelial ovarian cancer.
Elsharkawi SM; Elkaffash D; Moez P; El-Etreby N; Sheta E; Taleb RSZ
BMC Cancer; 2023 Jan; 23(1):89. PubMed ID: 36698136
[TBL] [Abstract][Full Text] [Related]
2. Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation.
Byzia E; Soloch N; Bodnar M; Szaumkessel M; Kiwerska K; Kostrzewska-Poczekaj M; Jarmuz-Szymczak M; Szylberg L; Wierzbicka M; Bartochowska A; Kalinowicz E; Grenman R; Szyfter K; Marszalek A; Giefing M
Mol Carcinog; 2018 Jul; 57(7):878-885. PubMed ID: 29566279
[TBL] [Abstract][Full Text] [Related]
3. Protocadherin-17 promoter methylation in serum-derived DNA is associated with poor prognosis of bladder cancer.
Luo ZG; Li ZG; Gui SL; Chi BJ; Ma JG
J Int Med Res; 2014 Feb; 42(1):35-41. PubMed ID: 24366498
[TBL] [Abstract][Full Text] [Related]
4. Aberrant promoter methylation reduced the expression of protocadherin 17 in nasopharyngeal cancer.
Yang S; Dai Z; Li W; Wang R; Huang D
Biochem Cell Biol; 2019 Aug; 97(4):364-368. PubMed ID: 30165032
[TBL] [Abstract][Full Text] [Related]
5. PCDH17 gene promoter demethylation and cell cycle arrest by genistein in gastric cancer.
Yang Y; Liu J; Li X; Li JC
Histol Histopathol; 2012 Feb; 27(2):217-24. PubMed ID: 22207556
[TBL] [Abstract][Full Text] [Related]
6. Protocadherin 17 promoter methylation in tumour tissue from patients with bladder transitional cell carcinoma.
Wang XB; Lin YL; Li ZG; Ma JH; Li J; Ma JG
J Int Med Res; 2014 Apr; 42(2):292-9. PubMed ID: 24567353
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of PCDH17 gene in high-grade serous ovarian carcinoma.
Baranova I; Kovarikova H; Laco J; Dvorak O; Sedlakova I; Palicka V; Chmelarova M
Cancer Biomark; 2018; 23(1):125-133. PubMed ID: 29991130
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma.
Lin YL; Wang YP; Li HZ; Zhang X
Med Sci Monit; 2017 Jul; 23():3318-3323. PubMed ID: 28688232
[TBL] [Abstract][Full Text] [Related]
9. Protocadherin17 Promoter Methylation is a Potential Predictive Biomarker in Clear Cell Renal Cell Carcinoma.
Lin YL; Gui SL; Guo H; Ma JG; Li WP
Med Sci Monit; 2015 Sep; 21():2870-6. PubMed ID: 26404644
[TBL] [Abstract][Full Text] [Related]
10. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers.
Hu X; Sui X; Li L; Huang X; Rong R; Su X; Shi Q; Mo L; Shu X; Kuang Y; Tao Q; He C
J Pathol; 2013 Jan; 229(1):62-73. PubMed ID: 22926751
[TBL] [Abstract][Full Text] [Related]
11. Methylation in the p53 promoter in epithelial ovarian cancer.
Chmelarova M; Krepinska E; Spacek J; Laco J; Beranek M; Palicka V
Clin Transl Oncol; 2013 Feb; 15(2):160-3. PubMed ID: 22855178
[TBL] [Abstract][Full Text] [Related]
12. Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer.
Yin X; Xiang T; Mu J; Mao H; Li L; Huang X; Li C; Feng Y; Luo X; Wei Y; Peng W; Ren G; Tao Q
Oncotarget; 2016 Aug; 7(32):51720-51732. PubMed ID: 27351130
[TBL] [Abstract][Full Text] [Related]
13. Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma.
Haruki S; Imoto I; Kozaki K; Matsui T; Kawachi H; Komatsu S; Muramatsu T; Shimada Y; Kawano T; Inazawa J
Carcinogenesis; 2010 Jun; 31(6):1027-36. PubMed ID: 20200074
[TBL] [Abstract][Full Text] [Related]
14. Methylation and Expression of Nonclustered Protocadherins Encoding Genes and Risk of Precancerous Gastric Lesions in a High-Risk Population.
Wu S; Zhang Y; Zhang L; Ma JL; Zhou T; Li ZX; Liu WD; Li WQ; You WC; Pan KF
Cancer Prev Res (Phila); 2018 Nov; 11(11):717-726. PubMed ID: 30213786
[TBL] [Abstract][Full Text] [Related]
15. Importance of promoter methylation of GATA4 gene in epithelial ovarian cancer.
Chmelarova M; Dvorakova E; Spacek J; Laco J; Palicka V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):294-7. PubMed ID: 24145767
[TBL] [Abstract][Full Text] [Related]
16. PCDH17 is regulated by methylation of DNMT3B and affects the malignant biological behavior of HCC through EMT.
Liu Y; Zhang Y; Du D; Gu X; Zhou S
Exp Cell Res; 2022 Sep; 418(1):113245. PubMed ID: 35688280
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation of protocadherin 17 and its prognostic value in pediatric acute lymphoblastic leukemia.
Uyen TN; Sakashita K; Al-Kzayer LF; Nakazawa Y; Kurata T; Koike K
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27643535
[TBL] [Abstract][Full Text] [Related]
18. Development of a multiplex MethyLight assay for the detection of DAPK1 and SOX1 methylation in epithelial ovarian cancer in a north Indian population.
Kaur M; Singh A; Singh K; Gupta S; Sachan M
Genes Genet Syst; 2016 Nov; 91(3):175-181. PubMed ID: 27452040
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation profile of ovarian epithelial neoplasms.
Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
[TBL] [Abstract][Full Text] [Related]
20. Se-Allylselenocysteine induces autophagy by modulating the AMPK/mTOR signaling pathway and epigenetic regulation of PCDH17 in human colorectal adenocarcinoma cells.
Wu JC; Wang FZ; Tsai ML; Lo CY; Badmaev V; Ho CT; Wang YJ; Pan MH
Mol Nutr Food Res; 2015 Dec; 59(12):2511-22. PubMed ID: 26395119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
